Rogers Corporation (ROG): Price and Financial Metrics


Rogers Corporation (ROG)

Today's Latest Price: $116.93 USD

6.12 (5.52%)

Updated Jun 3 3:02pm

Add ROG to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 35 in Technology - Electronics

See all "A" rated Strong Buy stocks

ROG Stock Summary

  • Rogers Corp's stock had its IPO on January 1, 1986, making it an older stock than 92.82% of US equities in our set.
  • ROG's current price/earnings ratio is 64.26, which is higher than 90.02% of US stocks with positive earnings.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.43 for Rogers Corp; that's greater than it is for just 20.12% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Rogers Corp are DHX, MTRN, ANGO, LTHM, and VIVO.
  • ROG's SEC filings can be seen here. And to visit Rogers Corp's official web site, go to www.rogerscorp.com.
ROG Daily Price Range
ROG 52-Week Price Range

ROG Stock Price Chart More Charts


ROG Price/Volume Stats

Current price $116.93 52-week high $183.34
Prev. close $110.81 52-week low $75.72
Day low $112.20 Volume 38,237
Day high $117.60 Avg. volume 155,722
50-day MA $101.05 Dividend yield N/A
200-day MA $121.73 Market Cap 2.18B

Rogers Corporation (ROG) Company Bio


Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company was founded in 1832 and is based in Rogers, Connecticut.

ROG Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$116.93$78.3-28%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Rogers Corp. To summarize, we found that Rogers Corp ranked in the 39th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Rogers Corp ended up being:

  • The company's debt burden, as measured by earnings divided by interest payments, is 7.31 -- which is good for besting 65.17% of its peer stocks (US stocks in the Technology sector with positive cash flow).
  • 88% of the company's capital comes from equity, which is greater than 75.55% of stocks in our cash flow based forecasting set.
  • The business' balance sheet reveals debt to be 12% of the company's capital (with equity being the remaining amount). Approximately only 24.41% of US stocks with free cash flow have a lower reliance on debt in their capital structure.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-29%
1%-28%
2%-28%
3%-27%
4%-26%
5%-26%

Want more companies with a valuation profile/forecast similar to that of Rogers Corp? See ACN, ALRM, EXLS, HPE, and TXN.


ROG Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ROG Latest Social Stream


Loading social stream, please wait...

View Full ROG Social Stream

Latest ROG News From Around the Web

Below are the latest news stories about Rogers Corp that investors may wish to consider to help them evaluate ROG as an investment opportunity.

Roche's shares rise on news of study testing Actemra, remdesivir in COVID-19 patients

Shares of Roche Holding AG gained 2.4% in premarket trading on Thursday after the drugmaker said it is testing a combination of its rheumatoid arthritis drug Actemra with Gilead Sciences Inc.'s remdesivir in hospitalized COVID-19 patients. Gilead's stock was down 0.4%. Roche has previously announced it is studying Actemra in 450 hospitalized COVID-19 patients participating in a randomized, double-blind, placebo-controlled late-stage trial; results from that trial are expected "this summer," Roche said. The new Phase 3, randomized, double-blind, multicenter study will test Actemra and remdesivir against placebo and remdesivir in about 450 patients hospitalized with severe COVID-19 pneumonia. Trial sites are in Canada, Europe, and the U.S. The Food and Drug Administration granted an eme...

Yahoo | May 28, 2020

Mobile phone sales 'very quiet' during pandemic store closures: Rogers CEO - BNN Bloomberg

The head of Canada's largest wireless business says sales of new mobile phones have been very quiet and likely won't pick up until customers return to stores and malls that have been temporarily closed due to the pandemic.

BNN Bloomberg | May 27, 2020

It’s Time to Consider Rogers (TSX:RCI.B)

Investors looking for a solid investment with growth and income-earning potential should strongly consider Rogers (TSX:RCI.B)(NYSE:RCI). The post It’s Time to Consider Rogers (TSX:RCI.B) appeared first on The Motley Fool Canada .

The Motley Fool Canada | May 26, 2020

Here’s why Rogers Corporation’s (NYSE:ROG) Returns On Capital Matters So Much

Today we are going to look at Rogers Corporation (NYSE:ROG) to see whether it might be an attractive investment...

Yahoo | May 21, 2020

Government to test remdesivir with Lilly drug in COVID-19 patients

The National Institute of Allergy and Infectious Diseases (NIAID) said Friday it is testing Gilead Sciences Inc.'s remdesivir in combination with Eli Lilly & Co.'s rheumatoid arthritis drug Olumiant in COVID-19 patients as part of the next phase of the randomized, controlled clinical trial that led to the authorization of remdesivir. This study will enroll 1,000 people at more than 100 sites in the U.S. and abroad, to "examine if adding an anti-inflammatory agent to the remdesivir regimen can provide additional benefit for patients," NIAID director Dr. Anthony Fauci said in a statement. The topline results from the remdesivir trial helped make up the basis of the Food and Drug Administration's (FDA) emergency use authorization for the drug last week. A number of medicines that have be...

Yahoo | May 8, 2020

Read More 'ROG' Stories Here

ROG Price Returns

1-mo 9.49%
3-mo 0.05%
6-mo -10.01%
1-year -20.30%
3-year 4.79%
5-year 63.26%
YTD -6.25%
2019 25.91%
2018 -38.82%
2017 110.81%
2016 48.94%
2015 -36.68%

Continue Researching ROG

Here are a few links from around the web to help you further your research on Rogers Corp's stock as an investment opportunity:

Rogers Corp (ROG) Stock Price | Nasdaq
Rogers Corp (ROG) Stock Quote, History and News - Yahoo Finance
Rogers Corp (ROG) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.5661 seconds.